MiMedx Publishes Document on its Website Exposing False and Misleading Information Distributed By Viceroy Research and Aurelius Value

MARIETTA, Ga., Sept. 29, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of...